Rockwell Automation Opens Registration for 2018 Automation Fair
Registration is now open for the 2018 Automation Fair, hosted by Rockwell Automation and members of its global PartnerNetwork program. The 27th annual Automation Fair will be held Nov. 12-15 at the Pennsylvania Convention Center. The event brings together approximately 10,000 manufacturers and producers from across the globe to learn about the newest innovations in automation and take part in training, industry forums and networking events.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180918005725/en/
Automation Fair will feature more than 150 exhibits showcasing the latest product innovations for industrial manufacturing and production. Hosted by Rockwell Automation and members of its PartnerNetwork, the event offers more than 400 hours of educational opportunities through forums, hands-on labs and technical sessions. (Photo: Business Wire)
“The next industrial transformation is here – and meeting its demands requires a more intelligent, connected and productive world,” said Blake Moret, chairman and CEO, Rockwell Automation. “Rockwell Automation is committed to delivering innovative solutions to help companies address their toughest production challenges. Automation Fair will deliver comprehensive learning, innovative technologies and forward-thinking solutions to help customers realize the potential of a Connected Enterprise.”
Automation Fair Show Floor
On Nov. 14 and 15, attendees can
explore more than 150 exhibits showcasing the latest product innovations
for industrial manufacturing and production from Rockwell Automation and
its PartnerNetwork members. The event provides more than 400 hours of
educational opportunities through forums, hands-on labs and technical
sessions.
Forums will feature best practices from customers and leaders on nine critical industry topics including chemical, food and beverage, life sciences, material handling, mining, OEMs and smart machines, power and energy, water wastewater and workforce development. Hands-on labs will deliver interactive product training, while technical sessions will provide lectures with cutting-edge use cases and demonstrations. Both offer tracks in control; information solutions; network infrastructure; power, motion and motor control; process solutions; safety and security; services and solutions; and visualization.
Process Solutions User Group (PSUG)
On Nov. 12 and 13
customers will discuss and learn about best practices, innovative
approaches and new technologies in process automation at PSUG. The event
will feature executive keynotes, 50 insightful technical and
customer-led sessions, and 10 hands-on labs addressing today’s most
relevant topics, including control strategies, optimization and process
safety.
Automation Perspectives Media Event
Global media and
industry analysts are invited to attend Automation Perspectives on Nov.
13. Rockwell Automation executives and industry leaders will showcase
how organizations are putting the Connected Enterprise into action to
expand human possibility; share strategies to address opportunities and
challenges in areas such as cybersecurity and workforce shortages; and
highlight key partnerships including how Rockwell Automation and PTC are
innovating together.
Registration for Automation Fair, PSUG and Automation Perspectives is now open.
About the Rockwell Automation PartnerNetwork Program
The
Rockwell Automation PartnerNetwork program offers global manufacturers
access to a collaborative network of companies mutually focused on
developing, implementing and supporting best-in-class solutions to
achieve plant-wide optimization, improve machine performance and meet
sustainability objectives.
About Rockwell Automation
Rockwell
Automation Inc. (NYSE: ROK), the world’s largest company dedicated
to industrial automation and information, makes its customers more
productive and the world more sustainable. Headquartered in Milwaukee,
Wis., Rockwell Automation employs approximately 22,000 people serving
customers in more than 80 countries.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180918005725/en/
Contact information
Rockwell Automation
Kristen Crump
414.544.2076
klcrump@ra.rockwell.com
or
Padilla
Beatrice
Zvosec
612.455.1914
beatrice.zvosec@padillaco.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 19:03:00 EEST | Press release
Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio
Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 18:43:00 EEST | Press release
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)
Suzano 2023 annual report on Form 20-F26.4.2024 18:22:00 EEST | Press release
Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/ Contact information Hawthorn Advisors suzano@hawthornadvisors.com
Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 15:30:00 EEST | Press release
Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new
MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms26.4.2024 15:00:00 EEST | Press release
The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption of the Capital Requirements Regulation (CRR3) amendments, which are part of a broader legislative package, including amendments to Directive 2013/36/EU, known as the Capital Requirements Directive or CRD. Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark change for the banking industry, designed to strengthen the framework for risk-based capital requirements and address ESG risks. “This is a major overhaul of the capital requirements framework, impacting various aspects, including credit risk, operational risk, market risk, and the capital floor. Whereas other significant jurisdictions, includin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom